Risk reduction of recurrent cardiovascular events in patients treated with the 20mg atorvastatin CNIC polypill compared to 3 active medication cohorts: a subanalysis of the NEPTUNO study
Event:
ESC Preventive Cardiology 2023
Topic:
Secondary Prevention
Session:
ePosters
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
